# Roche

World's largest biotech — pioneered monoclonal antibodies with Herceptin/Rituxan; Genentech subsidiary leads oncology and personalized medicine biologics R&D.

Source: https://en.bioecon.ru/companies/roche/
Updated: 2026-06-19

- Country: Switzerland
- Revenue: CHF 58.7B
- Employees: ~100,000 emp

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | CHF 62.598 billion (2025-12-31) | https://www.contractpharma.com/top-company-profile/roche/ |
| Funding | USD 50 billion investment in US pharmaceuticals and diagnostics over five years (2025-04-22) | https://assets.roche.com/f/308312/x/bdb6cdb7d2/ar25e.pdf, https://www.contractpharma.com/top-company-profile/roche/ |
| Production site | 13 manufacturing sites in the United States (2025-04-22) | https://assets.roche.com/f/176343/b7b5afd2b3/01-22042025_mr_roche-us-investment_en.pdf, https://www.roche.com/media/releases/med-cor-2025-04-22 |
| Production site | 65,000 square meter manufacturing facility in Holly Springs, North Carolina (2025-08-25) | https://www.contractpharma.com/top-company-profile/roche/, https://www.roche.com/media/releases/med-cor-2025-10-23 |
| Certification | EU-GMP, US-FDA, UK-MHRA, and Japan-PMDA certified facilities (2026-06-01) | https://chemxpert.com/company-group-details?param2=manufacturing_locations-group&param3=eu--gmp-certified-site&value=Roche+Group, https://chemxpert.com/download-summary-company?value=Roche+International+Ltd, https://chemxpert.com/download-summary-company?value=Roche+Pharma+Ag+Switzerland |
| Regulatory approval | FDA and EU approvals for various biologics including Gazyva/Gazyvaro, Ocrevus Zunovo, and Tecentriq Hybreza (2025-12-31) | https://assets.roche.com/f/176343/x/ca13f631d1/29012026_mr_fy_roche2025_english.pdf, https://pharmadossier.com/blog/roche-genentech-portfolio-dossier-subcutaneous-biologics-access, https://www.roche.com/media/releases/med-cor-2025-10-23 |

Independent sources: chemxpert.com, contractpharma.com, pharmadossier.com

## Technologies

- [Automated nucleic acid extraction](https://en.bioecon.ru/technology/automated-nucleic-acid-extraction/)
- [Biologics](https://en.bioecon.ru/technology/biologics/)
- [Bispecific & multispecific antibodies](https://en.bioecon.ru/technology/bispecific-antibodies/)
- [Diagnostics & biosensors](https://en.bioecon.ru/technology/diagnostics-biosensors/)